{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T07:13:57Z","timestamp":1681542837536},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T00:00:00Z","timestamp":1214352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002508","type":"journal-article","created":{"date-parts":[[2008,6,24]],"date-time":"2008-06-24T22:10:07Z","timestamp":1214345407000},"page":"e2508","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Generation of Small 32P-Labeled Peptides as a Potential Approach to Colorectal Cancer Therapy"],"prefix":"10.1371","volume":"3","author":[{"given":"John M.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Paun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatsugu","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Olaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin M.","family":"Selaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2008,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers.","volume":"314","author":"T Sjoblom","year":"2007","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers.","volume":"318","author":"LD Wood","year":"2007","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.","volume":"344","author":"DJ Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2 positive breast cancer.","volume":"353","author":"EH Romond","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1200\/JCO.2005.02.4091","article-title":"Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by placlitaxel, with or without trastuzumab as adjuvant therapy in node positive, human epidermal growth factor receptor 2-overexpressing breast cancer.","volume":"23","author":"E Tan-Chiu","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1200\/JCO.2000.18.17.3135","article-title":"Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of retreatment.","volume":"18","author":"TA Davis","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1158\/1078-0432.CCR-06-2110","article-title":"biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma.","volume":"13","author":"BI Rini","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1200\/JCO.2006.08.1620","article-title":"Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.","volume":"25","author":"E Van Cutsem","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1517\/14712598.7.5.739","article-title":"Bevacizumab in the treatment of colorectal cancer.","volume":"7","author":"JC Cilley","year":"2007","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1040-8428(01)00107-X","article-title":"Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-frade, follicular, or transformed B-cell non-Hodgkin's lymphoma.","volume":"39","author":"GA Wiseman","year":"2001","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1634\/theoncologist.9-2-160","article-title":"Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma.","volume":"9","author":"JM Vose","year":"2004","journal-title":"Oncologist"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"11896","DOI":"10.1158\/0008-5472.CAN-07-2967","article-title":"Predicting Response to radioimmunotherapy from the tumor microenvironment of colorectal cancers.","volume":"67","author":"EE Emir","year":"2007","journal-title":"Cancer Res."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1371\/journal.pone.0000964","article-title":"Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cells.","volume":"2","author":"JM Abraham","year":"2007","journal-title":"PLoS ONE"},{"key":"ref14","first-page":"532","article-title":"Immunotoxins for targeted cancer therapy AAPS J.","volume":"8","author":"RJ Kreitman","year":"2006"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/138945006778559139","article-title":"Immunotoxins in the treatment of hematologic malignancies. Curr.","volume":"7","author":"RJ Kreitman","year":"2006","journal-title":"Drug Targets"},{"key":"ref16","first-page":"44","article-title":"Recombinant toxins for the treatment of cancer.","volume":"5","author":"RJ Kreitman","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/187152007780618126","article-title":"Radionuclide therapy of cancer with radiolabeled antibodies.","volume":"7","author":"OC Boerman","year":"2007","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nbt1141","article-title":"Arming antibodies: prospects and challenges for immunoconjugates.","volume":"23","author":"AM Wu","year":"2005","journal-title":"Nat. Biotech."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/med.20002","article-title":"Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases.","volume":"24","author":"SM Okarvi","year":"2004","journal-title":"Med. Res. Rev."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/bip.10257","article-title":"Therapeutic Cancer Targeting Peptides.","volume":"66","author":"OH Aina","year":"2002","journal-title":"Biopolymers"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/092986607780090874","article-title":"Radiolabeled peptides and proteins in cancer therapy.","volume":"14","author":"C Wangler","year":"2007","journal-title":"Protein Pept. Lett."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/1535-7163.MCT-05-0029","article-title":"Identification of novel targeting peptides for human ovarian cancer cells using \u201cone bead one-compound\u201d combinatorial libraries.","volume":"4","author":"OH Aina","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref23","first-page":"196","article-title":"Radioimmunotherapy of solid tumors: The promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.","volume":"47","author":"RM Reilly","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/1078-0432.CCR-06-2436","article-title":"Optimization of radioimmunotherapy of solid tumors: Biological impediments and their modulation.","volume":"13","author":"M Jain","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ejca.2005.12.020","article-title":"Clinical applications of newer radionuclide therapies.","volume":"42","author":"B Brans","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1158\/1078-0432.CCR-05-0485","article-title":"Radioimmunotherapy for colorectal cancer.","volume":"11","author":"M Bertagnolli","year":"2005","journal-title":"Clin. Cancer Res."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T17:03:18Z","timestamp":1540314198000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002508"}},"subtitle":[],"editor":[{"given":"Edathara","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,6,25]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2008,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002508","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,25]]}}}